Ardea Biosciences, Inc.

Scrip regularly covers business development and deal making in the biopharmaceutical industry. Deal Watch is supported by deal intelligence from Biomedtracker. Novartis, Matchpoint Will Seek Out Oral

Cargo Therapeutics has managed to find a buyer after announcing in January that it would discontinue the Phase II study of its CD22-targeting CAR-T cell therapy firicabtagene autoleucel (firi-cel) due

Having jumped in front of the UK's Redx Pharma Plc to snap up Jounce Therapeutics, Inc. , Concerta Biosciences is looking to bag another embattled biotech, making a bid for the US antiviral speci

Less than a month after laying off half its staff and leaping onto a life raft thrown by Redx Pharma Plc , Jounce Therapeutics, Inc. has received a takeover offer from another suitor, little-known